mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.6 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
Vandetanib |
FIMM |
pan-cancer |
AAC |
-0.098 |
0.6 |
mRNA |
SB590885 |
GDSC1000 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
AP-24534 |
FIMM |
pan-cancer |
AAC |
0.092 |
0.6 |